Clinical trial
Maintaining Bone Strength in Men With Prostate Cancer
NCT00391950 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00391950 |
|---|---|
| Title | Maintaining Bone Strength in Men With Prostate Cancer |
| Official title | An Open-Label, Randomized, Multicentre Study to Evaluate the Efficacy of Two Zoledronic Acid Schedules on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Zoledronic acid |
| Enrollment | 300 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2007 |
| First posted | Oct 25, 2006 |
| Last update posted | Nov 23, 2009 |
| Countries | United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: